In this article, we will discuss the 13 Best Hot Stocks to Buy According to Analysts.
On March 6, Dan Niles, Niles Investment Management founder, joined ‘Power Lunch’ on CNBC to discuss the broader market sell-off and provide a cautious outlook on the current market environment. Addressing the broader sell-off triggered by the conflict involving Iran, Niles emphasized that the primary concern for investors is the duration of the war. While a short-term conflict of less than a month might be manageable, a long-term engagement could drive oil prices above $100, potentially leading to a global recession.
Niles observed a counterintuitive trend where software and the Mag 7 have outperformed since the conflict began. He defended his recent bullish stance on a software rally and noted that even with negative industry commentary and significant AI-driven layoffs, the software index still finished a recent week up 1% while the S&P 500 fell 0.4%. He argued that even if software faces a long-term decline similar to the 2001–2002 period, history shows that such cycles include massive countertrend rallies that can average 14% over two months.
Responding to concerns about market complacency and commodity shortages, Niles asserted that price leads the narrative, meaning that the market’s reaction to news is more telling than the news itself. While his personal belief is that stocks should be lower, he acknowledged that the market is signaling a potential resolution to the conflict. He advised investors to be hyper-selective and to get messy by diversifying into sectors with heavy assets that are less prone to AI-driven obsolescence.
Our Methodology
We used screeners to identify stocks that have gained at least 90% over the past 6 months and had an average upside potential of at least 30%. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Note: All data was sourced on March 16.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
13 Best Hot Stocks to Buy According to Analysts
13. Praxis Precision Medicines Inc. (NASDAQ:PRAX)
Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the best hot stocks to buy according to analysts. On February 19, Praxis Precision Medicines reported the financial results for Q4 2025, ending 2025 with $926 million in cash & investments. Following an additional $621 million financing in January, the company’s cash runway is now expected to fund operations into 2028. While R&D expenses rose to $267.1 million for the full year due to intensified clinical activity, the company has also expanded its leadership team and Board of Directors to support its upcoming commercial launches and long-term clinical strategy.
Praxis Precision Medicines Inc. submitted two NDAs to the FDA for ulixacaltamide, aimed at treating essential tremor, and relutrigine, for specific pediatric epileptic encephalopathies. Both therapies have received Breakthrough Therapy Designation, with ulixacaltamide notably being the first investigational therapy to show positive Phase 3 results for essential tremor.
The company is advancing several high-potential programs through its Cerebrum and Solidus platforms. Vormatrigine, a potent sodium-channel modulator for epilepsy, is expected to yield Phase 3 topline results in Q2 2026, while the antisense oligonucleotide elsunersen is on track for Phase 1/2 results in H1 2026. Beyond its late-stage assets, Praxis Precision Medicines intends to nominate three new development candidates by mid-2026 to address conditions such as autism spectrum disorders and intellectual disabilities, with regulatory submissions planned for the next two years.
Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system/CNS disorders characterized by neuronal excitation-inhibition imbalance in the US.
12. Spruce Biosciences Inc. (NASDAQ:SPRB)
Spruce Biosciences Inc. (NASDAQ:SPRB) is one of the best hot stocks to buy according to analysts. On March 9, Spruce Biosciences appointed Dale Hooks as Chief Commercial Officer to lead the company’s transition toward its next phase of growth. Hooks brings nearly 35 years of biopharmaceutical experience to the role, having overseen 21 new product launches throughout his career. His background includes leadership positions at Reata Pharmaceuticals, where he managed one of the most successful rare disease launches in US history, as well as executive roles at Applied Therapeutics, Clovis Oncology, and Genentech.
The appointment comes as Spruce Biosciences Inc. prepares for the planned BLA submission for tralesinidase alfa/TA-ERT, an enzyme replacement therapy for Sanfilippo Syndrome Type B/MPS IIIB. The CEO emphasized that Hooks’ expertise in building launch-ready infrastructure and commercial strategy will be critical as the company advances what could be the first disease-modifying treatment for this rare neurological disorder.
In his new role, Hooks will be responsible for shaping the commercial strategy and building high-performing teams to support the potential market entry of TA-ERT. He joins a leadership team currently focused on addressing significant unmet medical needs within the rare disease community.
Spruce Biosciences Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.
11. Capricor Therapeutics Inc. (NASDAQ:CAPR)
Capricor Therapeutics Inc. (NASDAQ:CAPR) is one of the best hot stocks to buy according to analysts. On March 12, Capricor Therapeutics presented new late-breaking data from its Phase 3 HOPE-3 clinical trial at the 2026 MDA Conference, highlighting the benefits of Deramiocel for Duchenne muscular dystrophy. Cardiac MRI results showed a reduction in myocardial fibrosis compared to the placebo group, with a notable improvement in left ventricular ejection fraction among patients with baseline cardiomyopathy. Additionally, a composite Global Statistical Test confirmed a statistically significant overall treatment benefit, integrating measures of physical function and patient perspective.
Functional outcomes also demonstrated that Deramiocel significantly slows disease progression related to daily activities. Data from the Duchenne Video Assessment specifically showed an 83% slowing of progression in tasks such as independent eating, which correlates with improved elbow and arm function observed in clinical testing. These findings suggest the therapy may help preserve patient independence by maintaining critical hand-to-mouth movements over time.
Capricor Therapeutics Inc. is currently moving toward potential commercialization, with a BLA under FDA review. Deramiocel has already received several special designations, including Orphan Drug and Regenerative Medicine Advanced Therapy status. The FDA has set a PDUFA target action date of August 22 to decide on the therapy’s approval for the US market.
Capricor Therapeutics Inc. is a clinical-stage biotechnology company that develops transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy/DMD and other diseases with unmet medical needs in the US.
10. Babcock & Wilcox Enterprises Inc. (NYSE:BW)
Babcock & Wilcox Enterprises Inc. (NYSE:BW) is one of the best hot stocks to buy according to analysts. On March 4, Babcock & Wilcox reported results for Q4 2025, with revenue of $161 million and a significant improvement in operating income, which rose to $12.2 million from $2.6 million in the prior year’s quarter. Full-year 2025 results show consolidated revenues of $587.7 million. These gains were supported by a 17% increase in parts & services revenue, driven by higher baseload demand and increased coal generation usage in North America. The company also narrowed its full-year loss from continuing operations to $32.8 million, down from $104.3 million in 2024.
The company announced a major strategic shift with a full notice to proceed on a $2.4 billion project for Base Electron, backed by Applied Digital. This initiative involves providing 1.2 GW of natural gas technology for AI Factory campuses, driving the company’s continuing operations backlog to $2.8 billion, a 470% increase compared to the end of 2024. This project, combined with a global pipeline that now exceeds $12 billion, positions Babcock & Wilcox as a key player in the high-capacity energy generation market required to support the rapid growth of AI and data center infrastructure.
The CEO noted that the company is uniquely positioned to capitalize on global demand for baseload generation, benefiting from Department of Energy mandates and the need for faster power solutions amid combustion turbine delays. Babcock & Wilcox Enterprises Inc. remains focused on converting its robust project pipeline into sustained growth as it enters 2026.
Babcock & Wilcox Enterprises Inc., together with its subsidiaries, provides energy and emissions control solutions to industrial, electrical utility, municipal, and other customers in the US, Canada, the UK, Indonesia, and the Philippines.
9. Nova Minerals Limited (NASDAQ:NVA)
Nova Minerals Limited (NASDAQ:NVA) is one of the best hot stocks to buy according to analysts. On March 9, Nova Minerals reported high-grade gold assay results from its 2025 surface sampling program at the RPM project, part of the Estelle Gold and Critical Minerals Project in Alaska. The program identified new gold anomalies to the west of the existing site and along the northern end of the RPM ridgeline. Key findings include rock samples grading up to 24.6 g/t Au and soil samples peaking at 5.5 g/t Au, building upon previous reconnaissance that returned values as high as 52.3 g/t Au.
Nova Minerals Limited designated the RPM ridgeline as a high-priority drill target for its 2026 exploration season. Technical data from drone magnetometry and geochemical sampling suggest that the northern extension of the ridge shares similar magnetic signatures and geological characteristics with the main RPM deposit. Geologists noted that the gold was found within stockwork quartz veining in both intrusive and hornfels host rocks, supporting the potential for high-grade pods similar to those previously discovered at RPM North.
Success at these new anomalies could provide significant upside for the broader Estelle Project, particularly due to their proximity to established access routes. While further investigation is required for the anomalies located to the west, the company intends to return in 2026 to expand on these targets. This upcoming program will focus on systematic drill testing to confirm the scale and grade of these recent surface discoveries.
Nova Minerals Limited explores mineral properties in Australia and the US. The company explores for gold, antimony, and critical minerals.
8. Micropolis AI Robotics (NYSEAMERICAN:MCRP)
Micropolis AI Robotics (NYSEAMERICAN:MCRP) is one of the best hot stocks to buy according to analysts. On March 3, Micropolis Robotics entered into a $9.3 million commercial agreement with AfricAI Limited to develop and distribute autonomous vehicle solutions across Africa. The 18-month development program focuses on creating three custom unmanned ground vehicle/UGV models specifically engineered for African climates and terrains. These platforms will be tailored for applications in police and public safety, agriculture, and border control missions.
The partnership includes a multi-year distribution agreement granting AfricAI exclusive rights within the Economic Community of West African States/ECOWAS, South Africa, the Democratic Republic of Congo, and Tanzania. AfricAI will market both the newly developed custom models and Micropolis’s existing M-Patrol units. The rollout strategy includes real-environment pilot testing at selected sites to validate the technology before full-scale commercialization.
This collaboration aims to accelerate the deployment of AI-driven robotics in high-growth regions where demand for intelligent automation is rising. Micropolis AI Robotics leadership noted that the agreement is a strategic step toward international expansion, allowing the company to deliver localized support while strengthening its commercial footprint. The initiative also supports AfricAI’s mission to scale sovereign, context-adapted AI capabilities throughout the continent.
Micropolis AI Robotics, together with its subsidiary, Micropolis Digital Development FZ-LLC, develops autonomous mobile robots/AMR in the UAE and Saudi Arabia.
7. Americas Gold and Silver Corporation (NYSEAMERICAN:USAS)
Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) is one of the best hot stocks to buy according to analysts. On March 12, Americas Gold and Silver Corporation announced the discovery of ten new high-grade veins at the Galena Complex, including 7 silver-copper-antimony veins and 3 silver-lead veins. These discoveries, resulting from late 2025 exploration, feature silver grades significantly higher than the project’s current mineral resources and reserves. Notable drill results include 4,896 g/t silver and 3.95% copper over 1.3 meters, as well as 2,563 g/t silver and 1.35% antimony over 0.7 meters.
Following these results, Americas Gold and Silver Corporation approved the largest drilling campaign in its history for 2026, totaling ~64,000 meters. This program will span operations in Idaho and Mexico, including the Galena Complex and the Cosalá site. A key component of the campaign involves mobilizing underground and surface rigs to the recently acquired Crescent Mine, a high-grade past producer that has not undergone systematic drilling in decades.
The exploration strategy targets numerous parallel and splay veins located near active mine workings, which the company views as immediate growth opportunities. Management indicated that these discoveries highlight the untapped potential of the Galena Complex after 120 years of operation. By investing in these high-grade discoveries, the company aims to support its current growth trajectory and strengthen its position as a North American precious metals and antimony producer.
Americas Gold and Silver Corporation, together with its subsidiaries, explores, develops, and produces mineral properties in the Americas. The company explores for gold, silver, zinc, lead, and other by-products.
6. Blue Moon Metals Inc. (NASDAQ:BMM)
Blue Moon Metals Inc. (NASDAQ:BMM) is one of the best hot stocks to buy according to analysts. On March 16, Blue Moon Metals finalized the acquisition of the Apex Mine from Teck American Incorporated, which is a subsidiary of Teck Resources Limited. Following the initial announcement in February, the transaction received TSX-V approval and resulted in Teck holding an 8.0% undiluted interest in Blue Moon through the issuance of over 7 million common shares. The acquired property consists of 24 patented and 9 unpatented claims focused on germanium and gallium production.
As part of the closing terms, Blue Moon granted Teck a 0.5% net smelter returns/NSR royalty on the property and assumed an existing 3.0% NSR royalty obligation. Additionally, both parties entered into an investor rights agreement that provides Teck with equity participation, top-up, and information rights. The companies also established a life-of-mine zinc off-take agreement for the Blue Moon Mine, with terms and treatment charges set according to current industry benchmarks.
The previously disclosed marketing agreement has been replaced by a formal off-take agreement for the Apex Mine claims. Under this arrangement, Teck will pay Blue Moon Metals Inc. the market value of the produced materials, less a fixed percentage, with the specific market value to be reassessed on an annual basis. The transaction was conducted at arm’s length, and no finder’s fees were paid in connection with the deal.
Blue Moon Metals Inc. explores and develops mineral resource properties in Norway and the US. The company explores for zinc, silver, gold, lead, germanium, gallium, and copper deposits.
5. Ultra Clean Holdings Inc. (NASDAQ:UCTT)
Ultra Clean Holdings Inc. (NASDAQ:UCTT) is one of the best hot stocks to buy according to analysts. On February 23, Ultra Clean Holdings reported Q4 2025 revenue of $506.6 million, with the Products division contributing $442.4 million and Services adding $64.2 million. The CEO noted that results met expectations despite a dynamic operating environment, emphasizing that the company is accelerating global execution to align with rising AI adoption.
While the quarter saw a GAAP net loss of $3.3 million, or $0.07 per diluted share, non-GAAP results showed a net income of $10.0 million, reflecting disciplined operational management as the company prepares for anticipated multi-year growth in the semiconductor industry. For the full year 2025, total revenue reached $2,054.0 million, a slight decrease from the $2,097.6 million reported in 2024.
Looking toward Q1 2026, Ultra Clean Holdings Inc. expects revenue to range between $505 million and $545 million, with non-GAAP diluted net income projected between $0.18 and $0.34 per share. The company continues to utilize its global manufacturing network to provide ultra-high purity cleaning, analytical services, and critical subsystems.
Ultra Clean Holdings Inc. develops and supplies critical subsystems, components & parts, and cleaning & analytical services for the semiconductor industry in the US and internationally.
4. Titan Mining Corporation (NYSEAMERICAN:TII)
Titan Mining Corporation (NYSEAMERICAN:TII) is one of the best hot stocks to buy according to analysts. On March 11, Titan Mining announced the commencement of graphite concentrate shipments from its demonstration facility in New York. As the only end-to-end producer of natural flake graphite in the US, the company is currently ramping up to nameplate capacity and initiating customer qualification shipments. This progress is part of a broader effort to address the country’s total reliance on imported graphite, which is a critical material for the defense, energy, and industrial sectors.
The company formally launched a fully-funded Feasibility Study for its Kilbourne Graphite Project, aiming for a large-scale integrated operation producing 40,000 tonnes per annum. This project is designed to supply ~50% of the current US demand for natural graphite. To support this expansion, infill and exploration drilling began in late 2025 to optimize mine design and increase existing mineral resource estimates, with a significant portion of the drilling already completed.
The Feasibility Study is co-funded by the Export-Import Bank of the United States to assist in securing project financing. A multidisciplinary engineering team is evaluating infrastructure requirements, processing optimization, and detailed cost estimates to transition the site into a full-scale mine and concentrator. Titan Mining Corporation is targeting a final construction decision for late 2026 or early 2027, with construction activities expected to begin shortly thereafter.
Titan Mining Corporation is a natural resource company that acquires, explores, develops, produces, and extracts mineral properties. The company explores for zinc and graphite, as well as iron-oxide copper gold deposits.
3. Lithium Argentina (NYSE:LAR)
Lithium Argentina (NYSE:LAR) is one of the best hot stocks to buy according to analysts. On March 11, Lithium Argentina announced an updated mineral resource and reserve estimate for its Cauchari-Olaroz brine operation in Jujuy Province, Argentina. The updated figures show a 42% increase in Measured and Indicated resources, now totaling 28.1 million tonnes of lithium carbonate equivalent/LCE with an average grade of 562 mg/L. This expansion was driven by a basin-wide hydrological model and new drilling that extended the resource area ~20 kilometers south of the previous footprint.
The new data is intended to support the Company’s Stage 2 development plans, which target an additional 45,000 tonnes per annum (or tpa) of LCE on top of the current Stage 1 capacity of 40,000 tpa. To facilitate this growth, Lithium Argentina filed applications for environmental permits and the Incentive Regime for Large Investments/RIGI in December 2025. A comprehensive technical report detailing these estimates is expected to be filed in March this year, with an updated Stage 2 development plan following in mid-2026.
Operationally, Stage 1 continues to perform near capacity with production costs maintained below $6,000 per tonne. The updated reserve model reaffirms a 35-year operating period from 2026 to 2060, aligning with the project’s original 40-year lifespan after accounting for prior production. Lithium Argentina stated that these results strengthen its goal of achieving a combined regional capacity of over 200,000 tpa LCE by using existing infrastructure and new technologies.
Lithium Argentina is a resource and materials company that advances lithium projects in Argentina. The company owns interests in the Cauchari-Olaroz project located in Jujuy province, and the Pastos Grandes project located in Salta Province of Argentina.
2. vTv Therapeutics Inc. (NASDAQ:VTVT)
vTv Therapeutics Inc. (NASDAQ:VTVT) is one of the best hot stocks to buy according to analysts. On March 10, vTv Therapeutics reported its financial results for Q4 and the full-year 2025. For 2025, the company reported a net loss of $27.0 million, with R&D expenses rising to $17.9 million due to increased investment in clinical trials for cadisegliatin. The company also highlighted advancements in the development of cadisegliatin, a potential first-in-class oral therapy for type 1 diabetes.
Throughout 2025, the company initiated patient dosing in the Phase 3 CATT1 trial and successfully expanded its scientific advisory board with internationally recognized experts. Despite a slower-than-expected start to patient recruitment, vTv Therapeutics Inc. increased its clinical site count and engagement efforts, leading to accelerated enrollment momentum. The company now expects to complete enrollment for the CATT1 trial in Q3 2026.
There was a notable expansion of a licensing agreement with Newsoara Biopharma Inc. in February. This amendment granted Newsoara exclusive worldwide rights to vTv’s PDE4 inhibitor, HPP737, in exchange for a $20.0 million upfront payment and potential future milestones totaling up to $115 million plus royalties. Additionally, vTv Therapeutics broadened the scope of cadisegliatin by submitting a Phase 2 clinical study protocol to the Abu Dhabi Department of Health to evaluate the therapy’s efficacy and safety in patients with type 2 diabetes, marking a key step in its international research efforts.
vTv Therapeutics Inc. is a late-stage biopharmaceutical company that develops oral small-molecule drug candidates intended to treat people living with diabetes and other chronic diseases.
1. Taseko Mines Limited (NYSEAMERICAN:TGB)
Taseko Mines Limited (NYSEAMERICAN:TGB) is one of the best hot stocks to buy according to analysts. On March 2, Taseko Mines Limited announced the first harvest of copper cathodes at its Florence Copper operation in Arizona. Following the late February startup of the facility’s electrowinning plant, this milestone marks the first new copper production from a greenfield site in the US since 2008. The project utilizes In-Situ Copper Recovery/ISCR, which is a low-cost extraction method designed to provide environmental advantages over traditional mining practices.
The facility is expected to produce ~1.5 billion pounds of copper over 22 years. Once it reaches its full annual capacity of 85 million pounds of LME Grade A copper, Taseko Mines Limited will become the third-largest copper cathode producer in the country. Company leadership noted that the construction of the commercial production facility was completed on schedule and within the established budget.
All copper produced at the site is intended to remain within the US to support domestic supply chain security and various manufacturing sectors, including aerospace, defense, and AI data centers. By providing a new domestic source of critical minerals, the operation aims to reduce reliance on copper imports during a period of rising global demand.
Taseko Mines Limited is a mining company that acquires and develops mineral properties. It explores for copper, molybdenum, gold, niobium, and silver deposits.
While we acknowledge the potential of TGB to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TGB and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
